Buscar
-
Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample
(Drug Safety. vol. 41, n° 11, pp. 1049-1058, 2018-11)Article de revue -
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
(Am J Cardiovasc Drugs. vol. 20, n° 1, pp. 81-103, 2020)Article de revue -
Does Ibuprofen Worsen COVID-19?
(Drug Safety. vol. 43, n° 7, pp. 611-614, 2020)Article de revue -
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database
(Atherosclerosis. vol. 281, pp. 98-106, 2019)Article de revue -
Pharmacovigilance - The next chapter
(Thérapie. vol. 74, n° 6, pp. 557-567, 2019-12)Article de revue -
Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation
(British Journal of Clinical Pharmacology. vol. 85, n° 2, pp. 432-441, 2019)Article de revue -
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study
(British Journal of Clinical Pharmacology. vol. 85, n° 11, pp. 2524-2539, 2019-11)Article de revueLibre acceso -
Pharmacoepidemiology of non-steroidal anti-inflammatory drugs
(Therapie. vol. 74, n° 2, pp. 271-277, 2019-04)Article de revue -
Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation
(Clinical Pharmacology and Therapeutics. vol. 105, n° 6, pp. 1439-1455, 2019)Article de revue -
Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015)
(Frontiers in Pharmacology. vol. 12, pp. 682890, 2021-11-03)Article de revueLibre acceso